Geron Corp (NASDAQ:GERN)

5.46
Delayed Data
As of Sep 21
 -0.04 / -0.73%
Today’s Change
1.74
Today|||52-Week Range
6.99
+203.33%
Year-to-Date

Today’s Trading

Previous close5.50
Today’s open5.50
Day’s range5.44 - 5.58
Volume13,469,992
Average volume (3 months)5,901,639
Market cap$1.0B
Data as of 4:00pm ET, 09/21/2018

Growth & Valuation

Earnings growth (last year)+5.26%
Earnings growth (this year)+161.11%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)-82.72%
P/E ratioNM
Price/Sales269.11
Price/Book8.41

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus BioSciences ...-0.40-2.45%
RYTMRhythm Pharmaceutica...+1.01+3.25%
ADAPAdaptimmune Therapeu...-0.26-2.17%
ZLABZai Lab Ltd-0.36-1.84%
Data as of 4:00pm ET, 09/21/2018

Financials

Next reporting dateNovember 8, 2018
EPS forecast (this quarter)$0.18
Annual revenue (last year)$1.1M
Annual profit (last year)-$27.9M
Net profit margin-2,621.22%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts